2019
First-in-Human Study of Paclitaxel Drug-Coated Chocolate Coronary Percutaneous Transluminal Coronary Angioplasty Balloon Catheter in De Novo Coronary Artery Lesions
Garcia-Lithgow C, Tirziu D, Zhou S, Bouras G, Shah T, Grubman D, Javier JJ, Mustapha JA, Abizaid A, Lansky AJ. First-in-Human Study of Paclitaxel Drug-Coated Chocolate Coronary Percutaneous Transluminal Coronary Angioplasty Balloon Catheter in De Novo Coronary Artery Lesions. JACC Cardiovascular Interventions 2019, 12: 2568-2570. PMID: 31857033, DOI: 10.1016/j.jcin.2019.08.044.Peer-Reviewed Original Research
2011
Initial experience with a dedicated coronary re‐entry device for revascularization of chronic total occlusions
Whitlow PL, Lombardi WL, Araya M, Wyman R, Torres H, Dauvergne C, Tsuchikane E, Lansky A, Thompson CA. Initial experience with a dedicated coronary re‐entry device for revascularization of chronic total occlusions. Catheterization And Cardiovascular Interventions 2011, 80: 807-813. PMID: 22121076, DOI: 10.1002/ccd.23417.Peer-Reviewed Original ResearchConceptsChronic total coronary occlusionsDistal true lumenRe-entry deviceTrue lumenAntegrade guidewireWire entrapmentTIMI 3 flowTotal coronary occlusionChronic total occlusionGuidewire penetrationConsecutive CTO lesionsPrimary endpointProspective registryClinical improvementSuccessful recanalizationCoronary perforationMajor complicationsCTO lesionsCoronary occlusionCTO interventionTotal occlusionLesion characteristicsSubintimal spaceRetrograde techniqueInitial experience